vs

Side-by-side financial comparison of ANAPTYSBIO, INC (ANAB) and DIGI INTERNATIONAL INC (DGII). Click either name above to swap in a different company.

DIGI INTERNATIONAL INC is the larger business by last-quarter revenue ($130.7M vs $108.2M, roughly 1.2× ANAPTYSBIO, INC). ANAPTYSBIO, INC runs the higher net margin — 45.8% vs 8.6%, a 37.2% gap on every dollar of revenue. On growth, ANAPTYSBIO, INC posted the faster year-over-year revenue change (151.1% vs 25.1%). Over the past eight quarters, ANAPTYSBIO, INC's revenue compounded faster (288.3% CAGR vs 11.5%).

AnaptysBio, Inc. is a clinical-stage biotechnology company focused on developing antibody-based immunotherapies for inflammatory diseases, immuno-oncology indications, and rare disease conditions. It primarily serves the U.S. market, advancing its innovative product candidate pipeline to address unmet medical needs via rigorous research and clinical development.

Digi International, Inc. is an American Industrial Internet of Things (IIoT) technology company based in Hopkins, Minnesota. Founded in 1985, they were best known in the early 1990s as a manufacturer of multi-line serial data serial cards for PC clones, allowing these machines to run multi-line bulletin board systems (BBSes). As this market began to wind down with the rise of the internet in the late 1990s, Digi began to concentrate on network attached devices and industrial monitoring.

ANAB vs DGII — Head-to-Head

Bigger by revenue
DGII
DGII
1.2× larger
DGII
$130.7M
$108.2M
ANAB
Growing faster (revenue YoY)
ANAB
ANAB
+126.0% gap
ANAB
151.1%
25.1%
DGII
Higher net margin
ANAB
ANAB
37.2% more per $
ANAB
45.8%
8.6%
DGII
Faster 2-yr revenue CAGR
ANAB
ANAB
Annualised
ANAB
288.3%
11.5%
DGII

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
ANAB
ANAB
DGII
DGII
Revenue
$108.2M
$130.7M
Net Profit
$49.6M
$11.3M
Gross Margin
64.0%
Operating Margin
61.8%
13.1%
Net Margin
45.8%
8.6%
Revenue YoY
151.1%
25.1%
Net Profit YoY
327.8%
7.7%
EPS (diluted)
$1.64
$0.29

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ANAB
ANAB
DGII
DGII
Q1 26
$130.7M
Q4 25
$108.2M
$122.5M
Q3 25
$76.3M
$114.3M
Q2 25
$22.3M
$107.5M
Q1 25
$27.8M
$104.5M
Q4 24
$43.1M
$103.9M
Q3 24
$30.0M
$105.1M
Q2 24
$11.0M
$105.2M
Net Profit
ANAB
ANAB
DGII
DGII
Q1 26
$11.3M
Q4 25
$49.6M
$11.7M
Q3 25
$15.1M
$10.0M
Q2 25
$-38.6M
$10.2M
Q1 25
$-39.3M
$10.5M
Q4 24
$-21.8M
$10.1M
Q3 24
$-32.9M
$11.9M
Q2 24
$-46.7M
$9.7M
Gross Margin
ANAB
ANAB
DGII
DGII
Q1 26
64.0%
Q4 25
62.4%
Q3 25
63.9%
Q2 25
63.5%
Q1 25
62.1%
Q4 24
62.0%
Q3 24
61.1%
Q2 24
59.2%
Operating Margin
ANAB
ANAB
DGII
DGII
Q1 26
13.1%
Q4 25
61.8%
13.3%
Q3 25
45.5%
12.5%
Q2 25
-117.5%
13.9%
Q1 25
-99.2%
13.1%
Q4 24
-22.4%
12.9%
Q3 24
-75.8%
14.2%
Q2 24
-367.5%
12.3%
Net Margin
ANAB
ANAB
DGII
DGII
Q1 26
8.6%
Q4 25
45.8%
9.6%
Q3 25
19.8%
8.7%
Q2 25
-173.5%
9.5%
Q1 25
-141.6%
10.0%
Q4 24
-50.5%
9.7%
Q3 24
-109.4%
11.3%
Q2 24
-425.3%
9.2%
EPS (diluted)
ANAB
ANAB
DGII
DGII
Q1 26
$0.29
Q4 25
$1.64
$0.31
Q3 25
$0.52
$0.26
Q2 25
$-1.34
$0.27
Q1 25
$-1.28
$0.28
Q4 24
$-0.63
$0.27
Q3 24
$-1.14
$0.32
Q2 24
$-1.71
$0.26

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ANAB
ANAB
DGII
DGII
Cash + ST InvestmentsLiquidity on hand
$238.2M
$31.7M
Total DebtLower is stronger
$143.0M
Stockholders' EquityBook value
$37.2M
$666.0M
Total Assets
$364.4M
$974.2M
Debt / EquityLower = less leverage
0.21×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ANAB
ANAB
DGII
DGII
Q1 26
$31.7M
Q4 25
$238.2M
$30.9M
Q3 25
$109.8M
$21.9M
Q2 25
$44.3M
$20.1M
Q1 25
$98.6M
$26.3M
Q4 24
$123.1M
$25.9M
Q3 24
$191.6M
$27.5M
Q2 24
$71.8M
$28.3M
Total Debt
ANAB
ANAB
DGII
DGII
Q1 26
$143.0M
Q4 25
$135.0M
Q3 25
$159.2M
Q2 25
$40.1M
Q1 25
$70.0M
Q4 24
$95.0M
Q3 24
$123.2M
Q2 24
$151.6M
Stockholders' Equity
ANAB
ANAB
DGII
DGII
Q1 26
$666.0M
Q4 25
$37.2M
$649.2M
Q3 25
$-29.4M
$636.1M
Q2 25
$-44.7M
$621.5M
Q1 25
$34.0M
$605.2M
Q4 24
$70.9M
$590.7M
Q3 24
$84.4M
$581.0M
Q2 24
$9.9M
$563.1M
Total Assets
ANAB
ANAB
DGII
DGII
Q1 26
$974.2M
Q4 25
$364.4M
$918.4M
Q3 25
$353.1M
$922.6M
Q2 25
$335.3M
$770.3M
Q1 25
$422.1M
$781.0M
Q4 24
$483.8M
$796.1M
Q3 24
$493.4M
$815.1M
Q2 24
$427.4M
$820.4M
Debt / Equity
ANAB
ANAB
DGII
DGII
Q1 26
0.21×
Q4 25
0.21×
Q3 25
0.25×
Q2 25
0.06×
Q1 25
0.12×
Q4 24
0.16×
Q3 24
0.21×
Q2 24
0.27×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ANAB
ANAB
DGII
DGII
Operating Cash FlowLast quarter
$98.0M
$77.1M
Free Cash FlowOCF − Capex
$98.0M
FCF MarginFCF / Revenue
90.5%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
1.98×
6.82×
TTM Free Cash FlowTrailing 4 quarters
$19.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ANAB
ANAB
DGII
DGII
Q1 26
$77.1M
Q4 25
$98.0M
$35.6M
Q3 25
$-27.4M
$28.0M
Q2 25
$-40.2M
$24.0M
Q1 25
$-10.7M
$26.3M
Q4 24
$-66.7M
$29.7M
Q3 24
$-10.1M
$26.4M
Q2 24
$-21.3M
$24.9M
Free Cash Flow
ANAB
ANAB
DGII
DGII
Q1 26
Q4 25
$98.0M
$35.2M
Q3 25
$-27.4M
$27.5M
Q2 25
$-40.3M
$22.9M
Q1 25
$-10.7M
$25.7M
Q4 24
$-66.9M
$29.1M
Q3 24
$-10.1M
$25.5M
Q2 24
$-21.4M
$24.5M
FCF Margin
ANAB
ANAB
DGII
DGII
Q1 26
Q4 25
90.5%
28.7%
Q3 25
-35.9%
24.1%
Q2 25
-180.9%
21.3%
Q1 25
-38.7%
24.6%
Q4 24
-155.3%
28.1%
Q3 24
-33.7%
24.3%
Q2 24
-194.6%
23.2%
Capex Intensity
ANAB
ANAB
DGII
DGII
Q1 26
Q4 25
0.0%
0.4%
Q3 25
0.0%
0.4%
Q2 25
0.2%
0.9%
Q1 25
0.1%
0.5%
Q4 24
0.6%
0.6%
Q3 24
0.1%
0.9%
Q2 24
0.3%
0.5%
Cash Conversion
ANAB
ANAB
DGII
DGII
Q1 26
6.82×
Q4 25
1.98×
3.04×
Q3 25
-1.81×
2.81×
Q2 25
2.34×
Q1 25
2.50×
Q4 24
2.95×
Q3 24
2.23×
Q2 24
2.57×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons